SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14C - Other preliminary information statements:
SEC Accession No. 0001654954-20-014028
Filing Date
2020-12-30
Accepted
2020-12-30 16:58:16
Documents
2
Period of Report
2020-12-30

Document Format Files

Seq Description Document Type Size
1 PRE 14C gtbp_pre14c.htm PRE 14C 223011
2 IMAGE gtbp_pre14c000.jpg GRAPHIC 2698
  Complete submission text file 0001654954-20-014028.txt   228207
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14C | Act: 34 | File No.: 000-08092 | Film No.: 201426473
SIC: 2834 Pharmaceutical Preparations